BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22994157)

  • 21. Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.
    Wawrzyniak E; Kotkowska A; Blonski JZ; Siemieniuk-Rys M; Ziolkowska E; Giannopoulos K; Robak T; Korycka-Wolowiec A
    Eur J Haematol; 2014 Feb; 92(2):91-101. PubMed ID: 24138550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fluorescence in Situ Hybridization for Detecting Molecular Cytogenetic Abnormalities of Chronic Lymphocytic Leukemia].
    Zhang HY; Yang YL; Zhao Q; Zhang J; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1474-1479. PubMed ID: 33067940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
    Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
    Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia.
    Chun K; Wenger GD; Chaubey A; Dash DP; Kanagal-Shamanna R; Kantarci S; Kolhe R; Van Dyke DL; Wang L; Wolff DJ; Miron PM
    Cancer Genet; 2018 Dec; 228-229():236-250. PubMed ID: 30554732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays.
    Li MM; Monzon FA; Biegel JA; Jobanputra V; Laffin JJ; Levy B; Leon A; Miron P; Rossi MR; Toruner G; Alvarez K; Doho G; Dougherty MJ; Hu X; Kash S; Streck D; Znoyko I; Hagenkord JM; Wolff DJ
    Cancer Genet; 2015 Nov; 208(11):525-36. PubMed ID: 26454669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chromosomal aberrations detection in chronic lymphocytic leukemia by conventional cytogenetics using DSP30 and IL-2].
    Liu HF; Huang HW; Bai SX; Gong YL; Wu CX; Jin ZM; Wang YY; Yang Q; Zhang J; Qiu HY; Chen SN; Pan JL
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):143-148. PubMed ID: 32135632
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
    Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
    Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of chromosomal abnormalities in chronic lymphocytic leukemia increased by interphase fluorescence in situ hybridization in tetradecanoylphorbol acetate-stimulated peripheral blood cells.
    Sánchez J; Aventín A
    Cancer Genet Cytogenet; 2007 May; 175(1):57-60. PubMed ID: 17498559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia.
    Gunn SR; Mohammed MS; Gorre ME; Cotter PD; Kim J; Bahler DW; Preobrazhensky SN; Higgins RA; Bolla AR; Ismail SH; de Jong D; Eldering E; van Oers MH; Mellink CH; Keating MJ; Schlette EJ; Abruzzo LV; Robetorye RS
    J Mol Diagn; 2008 Sep; 10(5):442-51. PubMed ID: 18687794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysis.
    Brejcha M; Stoklasová M; Brychtová Y; Panovská A; Štěpanovská K; Vaňková G; Plevová K; Oltová A; Horká K; Pospíšilová Š; Mayer J; Doubek M
    Leuk Res; 2014 Feb; 38(2):170-5. PubMed ID: 24246692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methods in molecular cytogenetics for determination of prognostically important chromosome changes in patients with chronic lymphatic leukemias].
    Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
    Cas Lek Cesk; 2000 Sep; 139(18):564-9. PubMed ID: 11109291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.
    Edelmann J; Holzmann K; Miller F; Winkler D; Bühler A; Zenz T; Bullinger L; Kühn MW; Gerhardinger A; Bloehdorn J; Radtke I; Su X; Ma J; Pounds S; Hallek M; Lichter P; Korbel J; Busch R; Mertens D; Downing JR; Stilgenbauer S; Döhner H
    Blood; 2012 Dec; 120(24):4783-94. PubMed ID: 23047824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.
    Gerrie AS; Huang SJ; Bruyere H; Dalal C; Hrynchak M; Karsan A; Ramadan KM; Smith AC; Tyson C; Toze CL; Gillan TL
    Cancer Genet; 2014; 207(7-8):316-25. PubMed ID: 25441686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations.
    Rigolin GM; del Giudice I; Formigaro L; Saccenti E; Martinelli S; Cavallari M; Lista E; Tammiso E; Volta E; Lupini L; Bassi C; Bardi A; Sofritti O; Daghia G; Cavazzini F; Marinelli M; Tavolaro S; Guarini A; Negrini M; Foà R; Cuneo A
    Genes Chromosomes Cancer; 2015 Dec; 54(12):818-26. PubMed ID: 26355802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genomic abnormalities detected by panel fluorescence in situ hybridization in chronic lymphocytic leukaemia].
    Li Q; Xue YQ; Jiang HY; Pan JL; Wu YF; Yang YB
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):324-6. PubMed ID: 15952127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: comparison with FISH.
    Kotkowska A; Wawrzyniak E; Blonski JZ; Robak T; Korycka-Wolowiec A
    Leuk Res; 2011 Aug; 35(8):1032-8. PubMed ID: 21333354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implications.
    Zenz T; Mertens D; Döhner H; Stilgenbauer S
    Leuk Lymphoma; 2008 May; 49(5):864-73. PubMed ID: 18452094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.